A recent study by Dr. Neil Sadick et al concluded that hair removal using Radiancy's Sensitive Care light unit assemblies (LUAs) effectively and safely achieve lasting hair removal Fitzpatrick Scale Skin Types V-VI. Due to the melanin level in these skin types, there is increased absorption of light which increases the possibility of side effects such as hyperpigmentation, hypopigmentation and burning.

Radiancy, established leaders in phototherapy, developed specialized lamps for photoepilation to increase safety without sacrificing efficacy. The Ruby Lamp for hair removal uses adjusted wavelengths that are more suitable for treating these skin types. Dr. Sadick performed his study to establish if these LUAs could perform safe and effective hair removal.

For his study, 23 women and 3 men participated in and completed all aspects of Dr. Sadick's study. Of these, 8 participants had Fitzpatrick skin type V and 18 had skin type VI. Dr. Sadick treated the legs, arms, bikini line, face, abdomen, axilla and back. Each patient underwent one treatment and was seen again at the 6 and 12 week follow-ups.

"Mistral is a cost-effective and powerful tool that can generate new sources of revenue in a popular and growing market," said Dr. Dolev Rafaeli PhD, CEO of Radiancy. "Fast treatments, unsurpassed safety and intelligent design come together to make Mistral the ultimate Radiancy product."

When the XL spot size combines with an accelerated pulse rate of 2-4 seconds, Mistral delivers the fastest treatment in the industry. The basic handpiece houses a spot size of 12 cm squared large by industry standards, and can be easily adjusted with snap-on adaptors to insure safe coverage of smaller areas.

Each handpiece is dedicated to a specific application, including Sensitive Care handpieces for Fitzpatrick skin types V-VI. "For some skin types, photo therapy can be harmful," commented Dr. Paul Sofer MD, head of Radiancy's clinical department. "These handpieces for skin photo rejuvenation and hair removal allow greater flexibility in choosing energy levels and enable the professional to create a safe and effective treatment solution."

At the core, a Windows CE custom-programmed platform simplifies operation and maintenance. "Taking advantage of the multi-dimensional capabilities of complete computer interface was the next logical step in LHE's development," said Gaby Cohen, Chief Technology Officer at Radiancy, "Mistral is very flexible and can be personalized to meet the needs of each individual operator." For instance, multilingual capabilities and touch-screen graphic interface streamline operation and shorten the learning curve. Preprogrammed protocols and intuitive user interface further simplify operation and facilitate altering between applications and treatment options. Mistral is easily upgraded, insuring that it remains compatible with all future innovations, such as the onboard patient database already under development.

Radiancy, Inc., the global leader in light-based skin therapies, announced today it has received U.S. Food and Drug Administration (FDA) 510(K) clearance to market the company's Skin Station phototherapy system to treat psoriasis. The company’s proprietary Light Heat Energy (LHE®) technology is already being used successfully in Europe, Asia and other countries to treat this chronic condition.

Results of clinical studies showed LHE phototherapy to be a safe and effective treatment for mild to moderate plaque and guttate psoriases. Patients in the study showed an average reduction of 65 percent on the Psoriasis Severity Index (PSI).

Radiancy’s LHE based phototherapy systems have previously been cleared by the FDA for hair removal and the treatment of  acne vulgaris and pigmented and vascular lesions on all skin types. Radiancy’s modular platform allows the psoriasis handpiece kit to attach quickly to Radiancy’s   SkinStation®, the company’s leading product. SkinStation incorporates today’s most sought after applications in one user-friendly system.
 “We are delighted to have received FDA approval to market our Psoriasis technology in the US,” says Fabian Tenenbaum, vice president of marketing and sales for Radiancy. “This new indication provides additional treatment benefits to patients and physicians and is testament to our ongoing commitment in improving the lives of skin sufferers around the world.”
Radiancy’s LHE technology combines special wavelengths of pulsed light with direct heat to treat psoriasis from the inside out. The device delivers green-yellow light that penetrates below the epidermis and through the plaque to the blood vessels that feed the plaque, explained Amos Leviav, M.D., head of plastic surgery at Kaplan Hospital, Rehovot, Israel, and lead investigator of the LHE psoriasis study.
The blood vessels are coagulated and destroyed via selective photothermolysis, resulting in eventual destruction of the plaque and its replacement by healthy tissue. The device also delivers red light and direct heat into the lesion to reduce swelling and inflammation and relieve itching.